Literature DB >> 22285174

Honokiol attenuates torsion/detorsion-induced testicular injury in rat testis by way of suppressing endoplasmic reticulum stress-related apoptosis.

Kuo-How Huang1, Te-I Weng, Hsin-Yi Huang, Kuo-Dong Huang, Wei-Chou Lin, Shyh-Chyan Chen, Shing-Hwa Liu.   

Abstract

OBJECTIVE: To investigate the protective effect of honokiol, a phytochemical used in traditional medicine, on testicular injury after torsion/detorsion (T/D) in a rat model. Testicular torsion is a medical emergency that can cause impairment of semen quality and permanent testicular atrophy or loss.
METHODS: Male Wistar rats were randomized to each time point of each group (n = 6/time point/group). After 2 hours of torsion, the testes were counter-rotated to the natural position. The rats in each group underwent a sham operation, T/D, or T/D with honokiol treatment (5 mg/kg and 10 mg/kg intraperitoneally, immediately before detorsion). Bilateral orchiectomy was performed at 6 and 24 hours and 3 months after detorsion. The testes were examined histologically. Apoptosis and endoplasmic reticulum stress were detected by Western blot.
RESULTS: Histologic examination revealed that testicular T/D induced acute injury after 6 and 24 hours, and spermatogenesis was decreased at 3 months of follow-up. At 24 hours after T/D, increases were found in the activation of apoptosis-related molecules [poly (ADP-ribose) polymerase and caspases 3 and 7], and the expression levels of endoplasmic reticulum stress-associated molecules (phosphorylated-eukaryotic translation initiation factor 2 subunit α and CCAAT/enhancer-binding protein homologous protein). These increases were significantly reversed with honokiol treatment. Furthermore, honokiol effectively reversed the inhibition of spermatogenesis in testes treated with T/D for 3 months.
CONCLUSION: The results of our study have shown that the endoplasmic reticulum stress-related apoptotic pathway is involved in testicular injury after testicular T/D. It remains to be determined whether alterations in this pathway would have a protective affect against reperfusion damage.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285174     DOI: 10.1016/j.urology.2011.11.027

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Role of p97/Valosin-containing protein (VCP) and Jab1/CSN5 in testicular ischaemia-reperfusion injury.

Authors:  Sevil Cayli; Seda Ocakli; Ufuk Senel; Nilnur Eyerci; Tuncay Delibasi
Journal:  J Mol Histol       Date:  2016-01-11       Impact factor: 2.611

2.  MiR-29a Suppresses Spermatogenic Cell Apoptosis in Testicular Ischemia-Reperfusion Injury by Targeting TRPV4 Channels.

Authors:  Jin-Zhuo Ning; Wei Li; Fan Cheng; Wei-Min Yu; Ting Rao; Yuan Ruan; Run Yuan; Xiao-Bin Zhang; Dong Zhuo; Yang Du; Cheng-Cheng Xiao
Journal:  Front Physiol       Date:  2017-11-29       Impact factor: 4.566

3.  Apoptosis Induction by Iron Radiation via Inhibition of Autophagy in Trp53+/- Mouse Testes: Is Chronic Restraint-Induced Stress a Modifying Factor?

Authors:  Hongyan Li; Bing Wang; Hong Zhang; Takanori Katsube; Yi Xie; Lu Gan
Journal:  Int J Biol Sci       Date:  2018-06-13       Impact factor: 6.580

4.  Honokiol protects rat hearts against myocardial ischemia reperfusion injury by reducing oxidative stress and inflammation.

Authors:  Yun Wang; Zhong-Ze Zhang; Yun Wu; Jia Zhan; Xiang-Hu He; Yan-Lin Wang
Journal:  Exp Ther Med       Date:  2012-10-25       Impact factor: 2.447

5.  Protective effects of honokiol on ischemia/reperfusion injury of rat ovary: an experimental study.

Authors:  Senem Yaman Tunc; Elif Agacayak; Neval Yaman Goruk; Mehmet Sait Icen; Abdulkadir Turgut; Ulas Alabalik; Cihan Togrul; Cenap Ekinci; Aysun Ekinci; Talip Gul
Journal:  Drug Des Devel Ther       Date:  2016-03-08       Impact factor: 4.162

Review 6.  The Natural Occurring Compounds Targeting Endoplasmic Reticulum Stress.

Authors:  Hai Liu; Jianqiong Yang; Linfu Li; Weimei Shi; Xiaoliang Yuan; Longhuo Wu
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-03       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.